@askdrnandi: The FDA has issued a new safety warning for GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound, over a potential risk of sudden vision loss. Here’s what patients need to know: 1️⃣ What is NAION? It’s a rare condition caused by reduced blood flow to the optic nerve. It can trigger sudden, painless vision loss, usually in one eye, and the damage may be permanent. 2️⃣ What are the warning signs? Sudden blurred vision, blind spots, or loss of vision in one eye require immediate medical attention, even without pain. 3️⃣ Should patients stop GLP-1 medications? Not without consulting their doctor. These drugs play a crucial role in managing type 2 diabetes and obesity, with proven cardiovascular and kidney benefits for certain patients. For me, this new warning reinforces the importance of weighing the benefits of GLP-1 treatment against potential risks and making sure patients know which symptoms require immediate attention. 📌 Save this video and share it with someone taking GLP-1 medications!#fyp #trending #gastroenterology #healthcare

Dr Nandi

Open In TikTok:

Region: US

Wednesday 11 November 2026 16:46:19 GMT